Generic Fosamax Users Must Give More Details In MDL
A New York federal judge on Wednesday ordered plaintiffs in multidistrict litigation against Teva Pharmaceuticals USA Inc. to divulge when they had taken a generic version of the bone drug Fosamax,...To view the full article, register now.
Already a subscriber? Click here to view full article